Brain, Vol. 125, No. 4, 812-822,
April 2002
© 2002 Guarantors of Brain
Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance
1 INN at Beth Israel Medical Center and 2 New York Eye and Ear Infirmary, New York, NY, USA
Correspondence to: Mark J. Kupersmith, MD, INN at Beth Israel North 170 East End Avenue, New York, NY 10128, USA E-mail: mkuper{at}bethisraelny.org
The location and extent of an abnormal signal on MRI of the optic nerve affected by optic neuritis are said to correlate with the severity of initial visual loss and recovery. We used gadolinium-enhanced fat-suppressed MRI to show abnormal enhancement of the optic nerve to determine the sensitivity of this modality in acute optic neuritis and whether the abnormal enhancement correlates with presenting visual deficits or recovery. A total of 107 patients, 93 with follow-up (68 steroid treated), were included; 101 patients had enhancement of the affected optic nerve and no unaffected nerve enhanced. The baseline visual performance was similar between nerves with and without enhancement. Optic nerves with enhancement in the optic canal had poorer colour vision (P = 0.04) and nerves with all segments involved had worse threshold perimetry (P = 0.001) and colour vision (P = 0.008). Nerves with enhancement >10 mm had worse threshold perimetry (P = 0.004), while nerves with enhancing segments >17 mm had poorer baseline visual acuity (P = 0.02), threshold perimetry (P = 0.009) and colour vision (P = 0.01). For all parameters of vision, recovery was similar regardless of location or length of abnormal enhancement. Abnormal contrast enhancement of the optic nerve is a sensitive (94%) finding in acute optic neuritis and is absent in unaffected or previously affected optic nerves. Although lesions involving the canal or longer segments of optic nerve have worse starting vision, the location and length of enhancement are not predictive of recovery.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J de la Cruz and M J Kupersmith Clinical profile of simultaneous bilateral optic neuritis in adults Br. J. Ophthalmol., May 1, 2006; 90(5): 551 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Barkhof, U. Held, J. H. Simon, M. Daumer, F. Fazekas, M. Filippi, J. A. Frank, L. Kappos, D. Li, S. Menzler, et al. Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials Neurology, November 8, 2005; 65(9): 1447 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M A Rocca, S J Hickman, L Bo, F Agosta, D H Miller, G Comi, and M Filippi Imaging the optic nerve in multiple sclerosis Multiple Sclerosis, October 1, 2005; 11(5): 537 - 541. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. Hickman, A. T. Toosy, S. J. Jones, D. R. Altmann, K. A. Miszkiel, D. G. MacManus, G. J. Barker, G. T. Plant, A. J. Thompson, and D. H. Miller A serial MRI study following optic nerve mean area in acute optic neuritis Brain, November 1, 2004; 127(11): 2498 - 2505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Hickman, A. T. Toosy, S. J. Jones, D. R. Altmann, K. A. Miszkiel, D. G. MacManus, G. J. Barker, G. T. Plant, A. J. Thompson, and D. H. Miller Serial magnetization transfer imaging in acute optic neuritis Brain, March 1, 2004; 127(3): 692 - 700. [Abstract] [Full Text] [PDF]
|
|